Seminar's Alan Rickman, Lily Rabe and Hamish Linklater Leave the Group Behind April 1 | Playbill

Related Articles
News Seminar's Alan Rickman, Lily Rabe and Hamish Linklater Leave the Group Behind April 1 Broadway's Seminar, the new play by Theresa Rebeck, loses Alan Rickman, Lily Rabe and Hamish Linklater following the April 1 matinee at the Golden Theatre. They exit at the end of their contracts, but newcomers are waiting in the wings.

//assets.playbill.com/editorial/2c3e70d21a6fd63aa6a6aba72539a5a9-SEMINAROPEN1200.jpg
Alan Rickman Photo by Jeremy Daniel

The play about a salty editor (Rickman) invited to judge the work of aspiring novelists (Rabe, Linklater, Hettienne Park and Jerry O'Connell) is directed by Sam Gold (The Big Meal, Look Back in Anger).

On April 3, Zoe Lister-Jones will succeed Rabe as Kate (who organizes the group); Jeff Goldblum will succeed Rickman as waspish literary lion Leonard; and Justin Long (TV's "Ed") will succeed Linklater as unsure writer Martin. Park and O'Connell continue in the roles of Izzy and Douglas, respectively.

The new quintet is set to play eight weeks, from April 3 through May 27.

Pulitzer Prize finalist and Peabody Award winner Theresa Rebeck also wrote the plays Mauritius, The Scene, The Understudy and Omnium Gatherum (among many others), was an "NYPD Blue" writer and created the NBC series "Smash."

Seminar opened Nov. 20, 2011, and is produced by Jeffrey Finn, Jill Furman, John N. Hart Jr., Patrick Milling Smith, Roy Furman, David Ian, David Mirvish, Amy Nauiokas and James Spry.

Tickets are $51.50-126.50, with Premium seating also available. Tickets can be purchased by visiting www.telecharge.com, calling (212) 239-6200 or going in person to The Golden Theatre box office (252 West 45th Street).

Visit www.SeminarOnBroadway.com.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!